Evidence map›Paper›PMID 9193292›Full record

SynthesisBMJ (Clinical research ed.)1997

Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease.

S Ebrahim, G D Smith

Open access · greenAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BMJ (Clinical research ed.), 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 12 pooled it
13.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 12 syntheses or guidelines pooled it, 315 citations in OpenAlex.

  1. Reduction in saturated fat intake for cardiovascular disease.The Cochrane database of systematic reviews · 2020
    Pooled it
  2. Reduction in saturated fat intake for cardiovascular disease.The Cochrane database of systematic reviews · 2020
    Pooled it
  3. Reduced or modified dietary fat for preventing cardiovascular disease.The Cochrane database of systematic reviews · 2012
    Pooled it
  4. Reduced or modified dietary fat for preventing cardiovascular disease.The Cochrane database of systematic reviews · 2011
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Guideline
  9. Pooled it
  10. Pooled it
  11. General practitioners' continuing education: a review of policies, strategies and effectiveness, and their implications for the future.The British journal of general practice : the journal of the Royal College of General Practitioners · 1998
    Pooled it
  12. Pooled it
  13. Trial
  14. Trial
  15. Hip fracture prevention with a multifactorial educational program in elderly community-dwelling Finnish women.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2013
    Trial
  16. Trial
  17. Trial
  18. Effectiveness of nurse-delivered cardiovascular risk management in primary care: a randomised trial.The British journal of general practice : the journal of the Royal College of General Practitioners · 2010
    Trial
  19. Trial
  20. Trial

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

S EbrahimDepartment of Primary Care and Population Sciences, Royal Free Hospital School of Medicine, London.
G D Smith
The Royal Free Hospital · GBUniversity of Bristol · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the effectiveness of multiple risk factor intervention in reducing cardiovascular risk factors, total mortality, and mortality from coronary heart disease among adults.

designSystematic review and meta-analysis of randomised controlled trials in workforces and in primary care in which subjects were randomly allocated to more than one of six interventions (stopping smoking, exercise, dietary advice, weight control, antihypertensive drugs, and cholesterol lowering drugs) and followed up for at least six months. SUBJECTS: Adults aged 17-73 years, 903000 person years of observation were included in nine trials with clinical event outcomes and 303000 person years in five trials with risk factor outcomes alone.

main outcome measuresChanges in systolic and diastolic blood pressure, smoking rates, blood cholesterol concentrations, total mortality, and mortality from coronary heart disease.

resultsNet decreases in systolic and diastolic blood pressure, smoking prevalence, and blood cholesterol were 4.2 mm Hg (SE 0.19 mm Hg), 2.7 mm Hg (0.09 mm Hg), 4.2% (0.3%), and 0.14 mmol/l (0.01 mmol/l) respectively. In the nine trials with clinical event end points the pooled odds ratios for total and coronary heart disease mortality were 0.97 (95% confidence interval 0.92 to 1.02) and 0.96 (0.88 to 1.04) respectively. Statistical heterogeneity between the studies with respect to changes in mortality and risk factors was due to trials focusing on hypertensive participants and those using considerable amounts of drug treatment, with only these trials showing significant reductions in mortality.

conclusionsThe pooled effects of multiple risk factor intervention on mortality were insignificant and a small, but potentially important, benefit of treatment (about a 10% reduction in mortality) may have been missed. Changes in risk factors were modest, were related to the amount of pharmacological treatment used, and in some cases may have been overestimated because of regression to the mean, lack of intention to treat analyses, habituation to blood pressure measurement, and use of self reports of smoking. Interventions using personal or family counselling and education with or without pharmacological treatments seem to be more effective at reducing risk factors and therefore mortality in high risk hypertensive populations. The evidence suggests that such interventions implemented through standard health education methods have limited use in the general population. Health protection through fiscal and legislative measure may be more effective.

Indexed as

Randomized Controlled Trials as TopicAdolescentAdultAgedAnticholesteremic AgentsBlood PressureBody WeightCoronary DiseaseDietFollow-Up StudiesHealth PromotionHumansHypercholesterolemiaMiddle AgedRisk FactorsSmoking CessationAnticholesteremic Agents

Identifiers

PMID9193292
PMCPMC2126863
OpenAlexW2060204451

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.